FN als StartseiteRealtimekurse aktiv
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 23,800 | 24,000 | 12:48 | |
| 23,800 | 24,000 | 11:50 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | |
|---|---|---|---|---|
| Mo | Hikma adds scale to US injectables business with Xellia acquisition | 2 | Alliance News | |
| Mo | Hikma bolsters US injectables offering with purchase of Danish competitor | 3 | City A.M. | |
| Mo | Hikma boosts injectables business with Xellia assets acquisition | 2 | Sharecast | |
| Mo | Hikma Pharma To Acquire Parts Of Xellia Pharma's US Finished Dosage Form Business And Assets | 205 | AFX News | |
| Mo | Hikma Pharmaceutical - Hikma acquires Xellia's assets | 2 | RNS | |
| 11.06. | Broker tips: Intertek, GSK, HIkma Pharmaceuticals | 5 | Sharecast | |
| 11.06. | FTSE 100 movers: Hikma boosted by Citi note; miners slump | 2 | Sharecast | |
| 11.06. | Citi hikes Hikma price target, cites 'healthy trends' for injectables and US Generics | 2 | Sharecast | |
| 05.06. | Hikma Pharmaceutical - Director/PDMR Shareholding | 1 | RNS | |
| 09.05. | Hikma Pharmaceutical - Director/PDMR Shareholding | 1 | RNS | |
| 29.04. | Collegium enters authorized generic agreement with Hikma for Nucynta franchise | 4 | Seeking Alpha | |
| 29.04. | Collegium Pharma Partners With Hikma For Authorized Generics Of Nucynta In US | 1 | RTTNews | |
| 25.04. | Hikma Pharmaceutical - Result of AGM | 1 | RNS | |
| 25.04. | Hikma Pharmaceuticals backs outlook after making strong start to 2024 | 2 | Alliance News | |
| 25.04. | Hikma: Pharma giant starts year strong as new product sales surge in key markets | 2 | City A.M. | |
| 25.04. | Hikma delivers strong Q1, holds on to guidance | 3 | Sharecast | |
| 25.04. | Hikma Pharma Projects 2024 Group Revenue To Grow In Range Of 4% - 6% | 288 | AFX News | |
| 25.04. | Hikma Pharmaceutical - Trading Statement | 3 | RNS | |
| 17.04. | Hikma Pharmaceutical - Director/PDMR Shareholding | 1 | RNS | |
| 15.04. | Hikma Pharmaceutical - Hikma appoints new President of Generics business | 102 | RNS |
Seite:
1 2 3 4 Weiter >>
61 Nachrichten in den letzten 12 Monaten
Das Unternehmen HIKMA PHARMACEUTICALS PLC kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 23,800 Euro und damit 0,00 % im Plus. Aus der Ausschüttung der letzten 12 Monate von insgesamt 0,66 Euro errechnet sich eine Dividendendrendite von +2,77 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
